Page last updated: 2024-10-16

quinacrine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

quinacrine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jing, B1
Jin, J1
Xiang, R1
Liu, M1
Yang, L1
Tong, Y1
Xiao, X1
Lei, H1
Liu, W1
Xu, H1
Deng, J1
Zhou, L1
Wu, Y1

Other Studies

1 other study available for quinacrine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.
    Cell death & disease, 2018, 05-22, Volume: 9, Issue:6

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Humans; Mem

2018